Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
The E Wolfson Medical Center currently manages 1 pending office action in the Chemistry & Materials technology area. This action is being handled by 1 distinct examiner, GERLA, STEPHANIE RAE. This examiner is the busiest examiner for the center, responsible for 1 busiest examiner pending action.
The pending workload is situated within 1 distinct art unit. This indicates a focused technical scope for the center's current chemistry filings. With 1 pending office action and 1 distinct examiner, the prosecution strategy is centralized, and the applicant must address the specific requirements of GERLA, STEPHANIE RAE.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GERLA, STEPHANIE RAE | 1 | 16.3% | +30.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17915722 | ULCERATIVE COLITIS DIET, FORMULAE, PRODUCTS AND METHODS THEREOF | GERLA, STEPHANIE RAE | 19d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17915722 | ULCERATIVE COLITIS DIET, FORMULAE, PRODUCTS AND METHODS THEREOF | GERLA, STEPHANIE RAE | 19d overdue |
| Art Unit | Apps |
|---|---|
| 1791 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17915722 | ULCERATIVE COLITIS DIET, FORMULAE, PRODUCTS AND METHODS THEREOF | GERLA, STEPHANIE RAE | 1791 | §103§112 | Non-Final OA | 19d overdue | Pending | Sep 29, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialThe E Wolfson Medical Center has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Stephanie Rae Gerla has the most, with 1 of The E Wolfson Medical Center's pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
